Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Year-over-year debt growth rate
Latest
0.11%
↓ 100% vs avg
Percentile
P49
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
192.60%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.11% |
| Q3 2025 | 7754.35% |
| Q2 2025 | 29.09% |
| Q1 2025 | -37.40% |
| Q4 2024 | -3.43% |
| Q3 2024 | -2.98% |
| Q2 2024 | 22.42% |
| Q1 2024 | 0.47% |
| Q4 2023 | -2.59% |
| Q3 2023 | -45.77% |
| Q2 2023 | -86.84% |
| Q1 2023 | 1.06% |
| Q4 2022 | -22.95% |
| Q3 2022 | -21.25% |
| Q2 2022 | -25.92% |
| Q1 2022 | -39.82% |
| Q4 2021 | -1.87% |
| Q3 2021 | 2.53% |
| Q2 2021 | -11.91% |
| Q1 2021 | -19.81% |
| Q4 2020 | -0.76% |
| Q3 2020 | -0.14% |
| Q2 2020 | 1.19% |
| Q1 2020 | -30.00% |
| Q4 2019 | 1.21% |
| Q3 2019 | -3.08% |
| Q2 2019 | 2.08% |
| Q1 2019 | 2.04% |
| Q4 2018 | -22.02% |
| Q3 2018 | 1.20% |
| Q2 2018 | 254.34% |
| Q1 2018 | 1.34% |
| Q4 2017 | 1.34% |
| Q3 2017 | 1.34% |
| Q2 2017 | 1.34% |
| Q1 2017 | 1.33% |
| Q4 2016 | 1.33% |
| Q3 2016 | 1.33% |
| Q2 2016 | 1.32% |
| Q1 2016 | -0.35% |